The analysis of human papillomavirus DNA in penile cancer tissue by in situ hybridization.

Primary penile cancer is a rare disease. Higher incidence rates occur in underdeveloped countries. Many studies have suggested an association between human papillomavirus (HPV) infection and penile cancer. Although HPV can affect the squamous epithelium of the male genitalia similarly to the female genital tract, the association between penile cancer and HPV remains unclear. In the present study, the HPV gene expression was examined in penile cancer tissue using in situ hybridization (ISH). The present study included 41 cases in which penectomy was performed and 3 cases in which tumor resection was performed to treat pathologically-diagnosed penile cancer at Yokohama City University Medical Center, and its 7 affiliated hospitals between April 1990 and March 2010. The penile cancer tissue was subjected to an ISH analysis, and the clinicopathological features and prognosis were investigated. A total of 5/44 cases (11.4%) showed the expression of high-risk HPV. None of the patients showed the expression of low-risk HPV. The associations between the expression of high-risk HPV, and age, tumor location, tumor size, T stage, pathological differentiation, nuclear grade, Broder's classification, pattern of invasion, Y-K grade, vascular invasion, lymphoid invasion, koilocytosis and lymph-node metastasis were then examined. Patients with a well-differentiated status (P=0.044) and Broder's Grade 1 (P=0.019) showed a significantly lower rate of HPV positivity. The HPV expression was not significantly associated with cancer specific survival (P=0.932). ISH using INFORM HPV III does not detect the HPV genotype, this method is easy to employ and may be useful for the diagnosis of penile cancer tissue, similarly to cervical cancer.

[1]  K. Stratton,et al.  A Contemporary Review of HPV and Penile Cancer. , 2016, Oncology.

[2]  E. Pirog Immunohistochemistry and in situ hybridization for the diagnosis and classification of squamous lesions of the anogenital region. , 2015, Seminars in diagnostic pathology.

[3]  G. Guimarães,et al.  Prognostic factors in patients with penile carcinoma and inguinal lymph node metastasis , 2015, International journal of urology : official journal of the Japanese Urological Association.

[4]  R. Melotti,et al.  Recurrence and progression in patients with non‐muscle invasive bladder cancer: Prognostic models including multicolor fluorescence in situ hybridization molecular grading , 2014, International journal of urology : official journal of the Japanese Urological Association.

[5]  C. Cohen,et al.  Automated In Situ Hybridization For Human Papilloma Virus , 2014, Applied immunohistochemistry & molecular morphology (Print).

[6]  C. Logie,et al.  HPV vaccine acceptability among men: a systematic review and meta-analysis , 2013, Sexually Transmitted Infections.

[7]  G. Sonpavde,et al.  Penile cancer: current therapy and future directions. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  A. Freeman,et al.  Genital lichen sclerosus/balanitis xerotica obliterans in men with penile carcinoma: a critical analysis , 2013, BJU international.

[9]  Matthew Hickman,et al.  Inequalities in the uptake of Human Papillomavirus Vaccination: a systematic review and meta-analysis , 2013, International journal of epidemiology.

[10]  P. Delvenne,et al.  Human papillomavirus, lichen sclerosus and penile cancer: a study in Belgium. , 2012, Vaccine.

[11]  J. Dillner,et al.  Penile cancer: epidemiology, pathogenesis and prevention , 2009, World Journal of Urology.

[12]  A. Giuliano,et al.  Factors associated with acquisition and clearance of human papillomavirus infection in a cohort of US men: a prospective study. , 2009, The Journal of infectious diseases.

[13]  A. Giuliano,et al.  The optimal anatomic sites for sampling heterosexual men for human papillomavirus (HPV) detection: the HPV detection in men study. , 2007, The Journal of infectious diseases.

[14]  A. Giuliano,et al.  Human Papillomavirus Prevalence and Type Distribution in Male Anogenital Sites and Semen , 2007, Cancer Epidemiology Biomarkers & Prevention.

[15]  M. Senba,et al.  The prevalence of human papillomavirus genotypes in penile cancers from northern Thailand , 2006, Journal of medical virology.

[16]  J. Berkhof,et al.  Presence of high‐risk human papillomavirus DNA in penile carcinoma predicts favorable outcome in survival , 2006, International journal of cancer.

[17]  F. Barea,et al.  Infection with human papillomaviruses of sexual partners of women having cervical intraepithelial neoplasia. , 2006, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[18]  F. Smedts,et al.  HPV in situ hybridization: Impact of different protocols on the detection of integrated HPV , 2005, International journal of cancer.

[19]  K. Horiguchi,et al.  Expression profiling of mouse placental lactogen II and its correlative genes using a cDNA microarray analysis in the developmental mouse placenta. , 2003, The Journal of reproduction and development.

[20]  P. Fuchs,et al.  Human papillomavirus-positive tonsillar carcinomas: a different tumor entity? , 2003, Medical Microbiology and Immunology.

[21]  L. Turek,et al.  Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx , 2003, International journal of cancer.

[22]  F. X. Bosch,et al.  Epidemiologic classification of human papillomavirus types associated with cervical cancer. , 2003, The New England journal of medicine.

[23]  A. Lopes,et al.  Human papillomavirus as a prognostic factor in carcinoma of the penis , 2001, Cancer.

[24]  D. Sidransky,et al.  Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. , 2000, Journal of the National Cancer Institute.

[25]  H. van Tinteren,et al.  Human papillomavirus, lichen sclerosus, and squamous cell carcinoma of the vulva: detection and prognostic significance. , 1994, Gynecologic oncology.

[26]  M. Furihata,et al.  High-risk human papillomavirus infections and overexpression of p53 protein as prognostic indicators in transitional cell carcinoma of the urinary bladder. , 1993, Cancer research.

[27]  P. Humphrey,et al.  Prevalence of human papillomavirus types 16 and 18 in squamous‐cell carcinoma of the penis: A retrospective analysis of primary and metastatic lesions by differential polymerase chain reaction , 1992, International journal of cancer.

[28]  F. Abdul-Karim,et al.  Detection and localization of human papillomavirus in penile condylomas and squamous cell carcinomas using in situ hybridization with biotinylated DNA viral probes. , 1989, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[29]  B. Rose,et al.  Short Communication Absence of Human Papillomavirus in Tonsillar Squamous Cell Carcinomas from Chinese Patients , 2003 .

[30]  F. Smedts,et al.  Relationship between human papillomavirus type 16 in the cervix and intraepithelial neoplasia. , 1999, Obstetrics and gynecology.

[31]  F. X. Bosch,et al.  Human papillomavirus and other risk factors for cervical cancer. , 1997, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[32]  K. Fujinaga,et al.  Detection of human papillomavirus deoxyribonucleic acid in penile carcinoma by polymerase chain reaction and in situ hybridization. , 1993, The Journal of urology.